The Limited Times

Now you can see non-English news...

Latest news of the coronavirus, live | FDA recommends licensing Johnson & Johnson vaccine

2021-02-26T22:31:24.198Z


The European Medicines Agency plans to approve the company's vaccine on March 11 | February closes as the month with the most deaths from covid-19 reported since April: 10,823


Note to readers: EL PAÍS openly offers essential information on the coronavirus during the crisis.

If you want to support our journalism,

subscribe here

.

The Ministry of Health has reported 10,823 deaths from covid-19 in February, the month with the most deaths reported from coronavirus since April. In the last day, it has registered 8,341 new infections and 329 deaths. However, the cumulative incidence has dropped from 200 cases per 100,000, for the first time since mid-December. On the other hand, the ministry has updated the vaccination strategy. In it, it is established that people who have passed the infection and are under 55 will receive a single dose of the vaccine six months after diagnosis. In addition, the new strategy establishes that once all those over 60 have been vaccinated, they will start with those under this age with diseases that make them more vulnerable to the virus. The European Medicines Agency plans to approve Johnson & Johnson's vaccine on March 11, according to Bloomberg, so it could join the vials of Pfizer, Moderna and AstraZeneca in the battle for immunization in the European Union. The President of the Government, Pedro Sánchez, defended this Friday the "health passport" that the European Union wants to launch. "The objective is to restore normalcy and tourism without increasing the risk to health," Sánchez stressed.

Source: elparis

All life articles on 2021-02-26

You may like

Trends 24h

Life/Entertain 2024-04-19T02:09:13.489Z
Life/Entertain 2024-04-19T19:50:44.122Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.